Newsletter

You are here

Animal research, Health, Scientific progress

09 - 06 - 2016

Pembrolizumab: an effective treatment against advanced melanomas

The Gustave Roussy research centre confirmed the effectiveness of pembrolizumab against advanced melanomas, a type of skin cancer. The clinical study Keynote-001, conducted for three years has shown that the treatment, first validated in mice, can prevent the cancer-linked deactivation of T cells of the immune system. Result: 40% of patients treated have had their lives lengthened by 24.4 months and 15% seem to be in complete remission.